Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Job Description SummaryGE HealthCare has manufactured an entirely new line-up of SIGNA MR powered by deep learning -based technologies and cutting-edge hardware. Magnetic Resonance Imaging has been a fast-growing imaging modality in Austria-Switzerland (ACH). GE HealthCare